The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial
Authors
Keywords
-
Journal
NATURE MEDICINE
Volume 27, Issue 11, Pages 1954-1960
Publisher
Springer Science and Business Media LLC
Online
2021-10-29
DOI
10.1038/s41591-021-01536-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Empagliflozin Effects on Pulmonary Artery Pressure in Patients with Heart Failure: Results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial
- (2021) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in heart failure with preserved and mildly reduced ejection fraction: rationale and design of the DELIVER trial
- (2021) Scott D. Solomon et al. EUROPEAN JOURNAL OF HEART FAILURE
- Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction
- (2021) Ambarish Pandey et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quality of life in heart failure with preserved ejection fraction: importance of obesity, functional capacity, and physical inactivity
- (2020) Yogesh N.V. Reddy et al. EUROPEAN JOURNAL OF HEART FAILURE
- SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control
- (2020) Martin R. Cowie et al. Nature Reviews Cardiology
- Atrial Dysfunction in Patients With Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation
- (2020) Yogesh N.V. Reddy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
- (2020) Milton Packer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
- (2020) William T Abraham et al. EUROPEAN HEART JOURNAL
- Baseline Characteristics of Patients with Heart Failure with Preserved Ejection Fraction in the EMPEROR‐Preserved Trial
- (2020) Stefan D. Anker et al. EUROPEAN JOURNAL OF HEART FAILURE
- Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure
- (2020) Deepak L. Bhatt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Heart Failure With Preserved Ejection Fraction In Perspective
- (2019) Marc A. Pfeffer et al. CIRCULATION RESEARCH
- Type 2 Diabetes Mellitus and Heart Failure: A Scientific Statement From the American Heart Association and the Heart Failure Society of America
- (2019) Shannon M. Dunlay et al. CIRCULATION
- Health-Related Quality of Life in Heart Failure With Preserved Ejection Fraction
- (2019) Alvin Chandra et al. JACC-Heart Failure
- Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial
- (2019) Michael E. Nassif et al. CIRCULATION
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Angiotensin–Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction
- (2019) Scott D. Solomon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Patients’ Willingness to Accept Mitral Valve Procedure-Associated Risks Varies Across Severity of Heart Failure Symptoms
- (2019) Shelby D. Reed et al. Circulation-Cardiovascular Interventions
- Empagliflozin restores lowered exercise endurance capacity via the activation of skeletal muscle fatty acid oxidation in a murine model of heart failure
- (2019) Hideo Nambu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Prevalence and correlates of coronary microvascular dysfunction in heart failure with preserved ejection fraction: PROMIS-HFpEF
- (2018) Sanjiv J Shah et al. EUROPEAN HEART JOURNAL
- Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction
- (2017) Emil Wolsk et al. EUROPEAN JOURNAL OF HEART FAILURE
- Epidemiology of heart failure with preserved ejection fraction
- (2017) Shannon M. Dunlay et al. Nature Reviews Cardiology
- B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction
- (2013) Dirk J. van Veldhuisen et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started